1.The role of bile acid dynamics in inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease
Si-Rui Yu ; Run Sun ; Mei-Ya Shi ; Mei Yang ; Kun Chen ; Qiong Pan ; Ling Zhao ; Ming-Yue Wu ; Jin Chai
Liver Research 2026;10(1):35-50
The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is higher among individuals with inflammatory bowel disease (IBD) than in the general population. Emerging evidence indicates that the development of MASLD in patients with IBD may occur independently of traditional metabolic risk factors, suggesting a unique pathophysiological mechanism distinct from conventional MASLD pathways. Bile acids (BAs), which act as critical signaling molecules in enterohepatic circulation, play an essential role in maintaining gastrointestinal homeostasis through bidirectional gut–liver axis communication. These molecules are increasingly recognized as pivotal regulators in the progression of both MASLD and IBD. While previous studies have characterized the dynamics of BA in blood or fecal samples under both conditions, a comprehensive understanding of their metabolic profiles and the associated interactions within the gut–liver axis is still lacking. This review synthesizes current evidence from studies employing BA metabolomics to investigate IBD and MASLD. By focusing on BA signatures, we summarize conserved alterations between these two conditions and their potential mechanisms of disease progression. Our review advances understanding of BA-mediated pathways in IBD and MASLD, providing a foundation for assessing their roles in contributing to the pathogenesis of MASLD in patients with IBD.
2.Association between PM 2.5 Chemical Constituents and Preterm Birth: The Undeniable Role of Preconception H19 Gene Variation.
Ya Long WANG ; Pan Pan SUN ; Xin Ying WANG ; Jun Xi ZHANG ; Xiang Yu YU ; Jian CHAI ; Ruo DU ; Wen Yi LIU ; Fang Fang YU ; Yue BA ; Guo Yu ZHOU
Biomedical and Environmental Sciences 2025;38(8):1016-1022
3.Pathogenesis and intervention strategies of abdominal aortic aneurysm:an update
Yue CHAI ; Hongming SHAO ; Wenbin WU ; Ting HAN ; Pei WANG ; Chunlin ZHUANG
Academic Journal of Naval Medical University 2025;46(6):790-797
Abdominal aortic aneurysm(AAA)is a degenerative vascular disease occurring in the lower segment of the aortic diaphragm,mainly manifested by irreversible dilatation of the entire artery,preferably in the elderly population.The pathogenesis of AAA is complex and involves multiple factors,with genetic variations and immune imbalances playing important roles.Its pathological changes mainly include inflammatory cell infiltration,degradation of stromal elastin,and smooth muscle cell death.Rupture of AAA is the most dangerous complication,with a high mortality.Surgery remains the only effective intervention,but carries certain risks and postoperative complications.Early intervention for small abdominal aortic aneurysms to slow down aneurysm expansion and achieve long-term survival is currently a focus of drug and technology research.This article reviews the pathogenesis of AAA and its intervention strategies,and summarizes the research on existing drugs and the use of new targets and technologies,so as to provide insights for better understanding and treatment of AAA.
4.Advances in Microfluidic Chip Based on Loop-mediated Isothermal Amplification Technology for Rapid Detection of Foodborne Pathogens
Yan-Zhu PAN ; Jia-Hua TANG ; Yue-Xiang CHAI ; Lu-Xi SHU ; Jia-Xin XIE ; Yan ZHANG
Chinese Journal of Analytical Chemistry 2025;53(9):1447-1456
Loop-mediated isothermal amplification(LAMP)is a newin vitronucleic acid amplification technique,which has been widely used in rapid detection of pathogenic bacteria,with advantages of high efficiency,simple operation and low cost.Microfluidic chip technique is a kind of miniaturized and integrated analytical technology,which integrates automation and high throughput,and can effectively avoid sample cross-contamination and has the advantages of high sample utilization rate and high cost-effectivenes.LAMP combined with microfluidic chip can detect multiple samples of the same pathogen at the same time or single samples of different pathogens at the same time,providing a new method for the rapid,field detection of pathogens.In this paper,the research progresses of LAMP microfluidic chip and its application in rapid detection of pathogenic bacteria in recent years were reviewed,and the future prospect was discussed.
5.Analysis of variation coefficient of SNR in phantom-based mammography quality control
Xigang SHEN ; Qinghuan CHAI ; Tingting JIANG ; Yue SHEN ; Qin XIAO ; Yajia GU
China Oncology 2025;35(8):784-791
Background and purpose:In the quality control of mammography,the signal-to-noise ratio(SNR)refers to the ratio of the useful signal intensity to the background noise in the image,which is one of the important indicators for measuring the quality of the image.The coefficient of variation(CoV)is a commonly used indicator to describe the consistency and repeatability of SNR.This study aimed to assess the stability and repeatability of mammographic device performance by analyzing the changes in SNR CoV in two-dimensional(2D)images and tomosynthesis images(referred to as Tomo images)under different exposure modes using three mammographic devices from different manufacturers.Methods:A polymethylmethacrylate(PMMA)phantom designed for mammography quality control was used to perform automatic exposure detection at PMMA thicknesses ranging from 20-80 mm,with actual compression thickness equivalent to the average density of the breast compressed to 21-103 mm under full-field digital mammography(FFDM),low-dose mammography and digital breast tomosynthesis(DBT)exposure modes.The CoV of SNR in 2D images and tomosynthesis images was calculated for different mammographic devices under different exposure modes and compression thicknesses.Results:Between the compression thicknesses equivalent to the average density of the breast from 21 mm to 103 mm under FFDM,low-dose mammography,and DBT exposure modes,the differences in SNR CoV of 2D images under different exposure modes among mammographic devices 1,2,and 3 were statistically significant only in the DBT exposure mode(P=0.003),with SNR CoV ranging from 0.188%to 0.720%,0.368%to 1.073%and 0.402%to 1.662%,respectively.There were no statistically significant differences in SNR CoV of 2D images among devices 1,2,and 3 under FFDM and low-dose exposure modes(P=0.060).Under the DBT exposure mode,there were no statistically significant differences in the SNR CoV of the first projection image and the 0° projection image of tomosynthesis among devices 1(2 angles),2,and 3(P=0.373,P=0.742,P=0.225,P=0.693,respectively).Conclusion:The SNR CoV in 2D images and tomosynthesis images varies under different mammographic devices and exposure modes,with no fixed or standard values,but all within the required range for mammographic device quality control.The stability and repeatability of 2D images of mammographic devices are better under FFDM and low-dose exposure modes;the SNR CoV values of the first projection image and the 0° projection image of tomosynthesis under the DBT exposure mode show no statistical differences,indicating good stability of the devices.
6.Analysis of medication use in sample pediatric hospitals
Yue DU ; Jiali LI ; Yu CHAI ; Shaoqing CHEN ; Qi ZHAN
Journal of Pharmaceutical Practice and Service 2025;43(12):631-636
Objective To analyze the usage of pediatric drugs in 17 pediatric specialty hospitals from 2016 to 2020, and provide reference and guidance for the development of the essential medicine list (EML) for children and the improvement of the National Reimbursement Drug List (NRDL) in China. Methods Based on the pediatric medication monitoring data from 17 children's specialized hospitals reported to the Chinese Medical Economic Information Network (CMEI) of the Chinese Pharmaceutical Association between 2016 and 2020, this study analyzes the overall situation of the sample hospitals and the clinical use of pediatric drugs according to the major categories of the Anatomical Therapeutic Chemical Classification System (ATC). Results In the various ATC categories, the trend of systemic use of anti-infective drugs decreasing was significant in the average hospital expenditure, while the trend of respiratory and digestive system and metabolic drugs decreasing was significant in the average hospital DDDS. In 2020, the average number of hospital grade standards for essential drugs (2018 version) accounted for 15.82% of the total number of drug use standards, while the average number of hospital grade standards for medical insurance (2019 version) accounted for 8.23% of the total number of drug use standards. Conclusion The use of pediatric medication in sample hospitals from 2016 to 2020 was generally reasonable, and there would still a certain gap between the actual clinical usage habits with the existing EML and NRDL,which still need to be adjusted.
7.Baicalein inhibits lipopolysaccharide-induced microglial activation via the AKT/GSK3 β pathway
Yan ZHAO ; Hui XU ; Yana FU ; Yuanyuan YUE ; Xuejie CHAI ; Yongzheng LI
Chinese Journal of Neuroanatomy 2025;41(1):73-79
Objective:To investigate the effects of baicalein on the protein kinase B(AKT)/glycogen synthase kinase 3β(GSK3β)pathway and the expression of tumor necrosis factor-α(TNF-α)and interleukin-1 β(IL-1 β)in lipopolysaccharide(LPS)-activated BV2 microglial cells.Methods:BV2 microglial cells were cultured and divided into control group,LPS-induced group,and LPS+Baicalein group.Molecular docking was conducted to verify the bind-ing affinity of baicalein to AKT.Western blot and immunofluorescence staining were used to assess the expression and phosphorylation levels of AKT,GSK3β,TNF-α,and IL-1β in activated BV2 cells.Results:Baicalein exhibited a strong binding affinity for AKT.Western blot results showed that LPS stimulation led to increased TNF-α and IL-1 βexpression and decreased phosphorylation of AKT and GSK3β in BV2 cells(P<0.05).After Baicalein treatment,TNF-α and IL-1 β expression significantly decreased,while AKT and GSK3β phosphorylation levels increased compared to the LPS group(P<0.05).Immunofluorescence staining results were consistent with those of Western blot.Conclusion:Baicalein inhibits the expression of TNF-α and IL-1 β in activated microglia,potentially through activation of the AKT/GSK3β pathway.
8.Research Progress of Rare Tumor Organoid Model
Yifei YU ; Yue CHAI ; Jie ZHOU
JOURNAL OF RARE DISEASES 2025;4(4):406-413
Rare tumors pose significant challenges to clinical research, diagnosis, and therapy due to their low incidence, high molecular heterogeneity, and the lack of preclinical models.Conventional patient-derived cell lines and patient-derived tumor xenografts have significant limitations in recapitulating the characteristics of rare tumors. As an emerging
9.Research progress on the correlation between angiopoietin-like protein 2 and lower extremity arteriosclerosis obliterans
Yizhou LIU ; Xuezhen CHAI ; Zebin YU ; Yue LIANG
International Journal of Surgery 2025;52(3):199-204
Lower extremity arteriosclerosis obliterans(LEASO) is a disease in which systemic atherosclerosis affects the blood-supplying arteries of the lower extremities, resulting in chronic ischemia of the lower extremities. Angiopoietin-like protein 2(Angptl2) is a newly discovered pro-inflammatory protein that promotes the development of atherosclerosis by inducing vascular inflammatory responses. It is closely associated with certain risk factors for LEASO, such as advanced age, obesity, and type 2 diabetes. In addition, the high expression of Angptl2 in LEASO correlates with the continued progression of LEASO and may reflect the severity of the disease, suggesting that Angptl2 may be an important serologic biomarker for LEASO. In this article, we review the progress of research on the correlation between Angptl2 and LEASO, and analyze the value of Angptl2 as a biomarker for LEASO.
10.Expert consensus on holistic integrative management of oral squamous cell carcinoma
Moyi SUN ; Zongxuan HE ; Haoyue XU ; Xiaoying LI ; Jie ZHANG ; Haijun LU ; Xiaohong ZHAN ; Dapeng HAO ; Shizhu BAI ; Wei GUO ; Zhangui TANG ; Guoxin REN ; Jian MENG ; Zhijun SUN ; Jichen LI ; Yue HE ; Chunjie LI ; Lizheng QIN ; Kai YANG ; Qing XI ; Lin KONG ; Bing HAN ; Lingxue BU ; Yuanyong FENG ; Kai SONG ; Hongyu HAN ; Jieying LI ; Qianwei NI ; Yun LI ; Juan CHAI ; Xiaochen YANG ; Man HU ; Mingjin XU ; Wei SHANG
Journal of Practical Stomatology 2025;41(4):437-449
Oral squamous cell carcinoma(OSCC)is a malignant lesion originating from the oral mucosal squamous epithelium,account-ing for over 80%of oral and maxillofacial malignancies.Key etiological factors include tobacco,alcohol abuse,and betel quid chewing.In China,its incidence has shown an overall upward trend,posing a significant threat to public health.OSCC exhibits high local invasive-ness,making early diagnosis critical for improving prognosis.Its clinical management requires close multidisciplinary collaboration among oral and maxillofacial surgery,head and neck surgery,radiation oncology,medical oncology,reconstructive surgery,radiology,patholo-gy,and nutritional support teams.Given the increasing disease burden of OSCC and rapid development of multidisciplinary collaborative models,an expert panel has formulated this integrated management consensus based on evidence-based medicine and extensive deliber-ation.Centered on the'Prevention-Screening-Diagnosis-Treatment-Rehabilitation'framework,the consensus provides comprehensive guidance for the entire disease course of OSCC patients,aiming to standardize clinical practice.


Result Analysis
Print
Save
E-mail